home.social

#rettsyndrome — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #rettsyndrome, aggregated by home.social.

fetched live
  1. European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union

    SAN DIEGO, August 24, 2026–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European …
    #Europe #EU #ACADIAPharmaceuticals #DAYBU #EuropeanCommission #EuropeanUnion #neurodevelopmentaldisorder #pediatricpatients #raredisease #Rettsyndrome #treatmentoption #treatmentoptions
    europesays.com/europe/122619/

  2. DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

    — European Commission decision expected in the coming months — If approved, DAYBU® would become the first treatment…
    #Europe #EU #ACADIAPharmaceuticals #DAYBU #EuropeanCommission #EuropeanMedicinesAgency #EuropeanUnion #Forward-LookingStatements #marketingauthorization #Rettsyndrome #trofinetide
    europesays.com/europe/80006/

  3. This is Why Taysha Gene Therapies, Inc. (TSHA) is one of the Best Healthcare Penny Stocks to Buy

    Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best healthcare penny stocks to buy according to hedge…
    #NewsBeep #News #Healthcare #AU #Australia #Canaccord #genetherapies #Health #Rettsyndrome
    newsbeep.com/au/614197/

  4. This is Why Taysha Gene Therapies, Inc. (TSHA) is one of the Best Healthcare Penny Stocks to Buy

    Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best healthcare penny stocks to buy according to hedge…
    #NewsBeep #News #Healthcare #Canaccord #genetherapies #Health #healthcare #Rettsyndrome #UK #UnitedKingdom
    newsbeep.com/uk/535221/

  5. `These data set the stage for a potential therapeutic strategy using antisense oligonucleotides to promote isoform switching in patients with RTT who carry partially functioning alleles of MECP2.`

    science.org/doi/10.1126/scitra

    #Rett #RettSyndrome #geneTherapy #antisense

  6. `These data set the stage for a potential therapeutic strategy using antisense oligonucleotides to promote isoform switching in patients with RTT who carry partially functioning alleles of MECP2.`

    science.org/doi/10.1126/scitra

    #Rett #RettSyndrome #geneTherapy #antisense

  7. `These data set the stage for a potential therapeutic strategy using antisense oligonucleotides to promote isoform switching in patients with RTT who carry partially functioning alleles of MECP2.`

    science.org/doi/10.1126/scitra

    #Rett #RettSyndrome #geneTherapy #antisense

  8. `These data set the stage for a potential therapeutic strategy using antisense oligonucleotides to promote isoform switching in patients with RTT who carry partially functioning alleles of MECP2.`

    science.org/doi/10.1126/scitra

    #Rett #RettSyndrome #geneTherapy #antisense

  9. instagram.com/reel/DVGWNjKDPJk

    Handiski 2026 is not a “nice activity”.
    It’s dignity in motion.

    In February, 6 families.
    6 girls with Rett syndrome.
    3 days in La Bresse.
    Full inclusion. Full access. Zero financial barrier.

    Ski sessions adapted.
    Siblings in ski school.
    Parents breathing for once.

    This is what inclusion looks like when you stop talking and start funding.

    Support the mission 👉 alsr.lu
    #Handiski #RettSyndrome #Inclusion #DisabilityRights #ALSR

  10. Handiski 2026 is not a “charity trip.”

    It’s training.
    It’s courage.
    It’s trust.

    Five girls.
    Adaptive equipment.
    Cold mornings.
    Zero excuses.

    When you see a wheelchair on snow, you don’t see limits.
    You see logistics, teamwork, and pure determination.

    We’re preparing.
    #Handiski2026 #RettSyndrome #AdaptiveSport #Inclusion

  11. Handiski 2026 is officially loading ❄️

    After La Bresse 2025, we’re going back to the mountains with the girls of ALSR.
    Skiing. Laughter. Cold air. Real freedom.

    For girls living with Rett syndrome, this isn’t “just” a trip.
    It’s mobility. Inclusion. Dignity. Joy.

    More soon.
    #Handiski2026 #RettSyndrome #Inclusion #Luxembourg

  12. Brilliant work by #WhiteheadInstitute researchers and collaborators unpacking MECP2’s complex role in Rett syndrome - as both a gene activator and repressor. A powerful step toward more targeted therapies. #RettSyndrome #Neuroscience #Genetics #MECP2 #ScienceMatters #JaenischLab #YoungLab

    RE: https://bsky.app/profile/did:plc:376brirdwae4fayb4sd3bzdy/post/3lp5hlxwl722j

  13. Brilliant work by #WhiteheadInstitute researchers and collaborators unpacking MECP2’s complex role in Rett syndrome - as both a gene activator and repressor. A powerful step toward more targeted therapies. #RettSyndrome #Neuroscience #Genetics #MECP2 #ScienceMatters #JaenischLab #YoungLab

    RE: https://bsky.app/profile/did:plc:376brirdwae4fayb4sd3bzdy/post/3lp5hlxwl722j

  14. Brilliant work by #WhiteheadInstitute researchers and collaborators unpacking MECP2’s complex role in Rett syndrome - as both a gene activator and repressor. A powerful step toward more targeted therapies. #RettSyndrome #Neuroscience #Genetics #MECP2 #ScienceMatters #JaenischLab #YoungLab

    RE: https://bsky.app/profile/did:plc:376brirdwae4fayb4sd3bzdy/post/3lp5hlxwl722j

  15. new paper: "Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?" doi.org/10.3389/fmed.2024.1425

    "Rett syndrome (RTT) and Rett-like syndromes [i.e., CDKL5 deficiency disorder (CDD) and FOXG1-syndrome] represent rare yet profoundly impactful neurodevelopmental disorders (NDDs). [..] The current landscape of DR efforts in these syndromes is thoroughly examined [..]"

    #rettSyndrome #bioinformatics #drugRepurposing

  16. new paper: "Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?" doi.org/10.3389/fmed.2024.1425

    "Rett syndrome (RTT) and Rett-like syndromes [i.e., CDKL5 deficiency disorder (CDD) and FOXG1-syndrome] represent rare yet profoundly impactful neurodevelopmental disorders (NDDs). [..] The current landscape of DR efforts in these syndromes is thoroughly examined [..]"

    #rettSyndrome #bioinformatics #drugRepurposing

  17. new paper: "Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?" doi.org/10.3389/fmed.2024.1425

    "Rett syndrome (RTT) and Rett-like syndromes [i.e., CDKL5 deficiency disorder (CDD) and FOXG1-syndrome] represent rare yet profoundly impactful neurodevelopmental disorders (NDDs). [..] The current landscape of DR efforts in these syndromes is thoroughly examined [..]"

    #rettSyndrome #bioinformatics #drugRepurposing

  18. It seems that a genetic mutation may not have the same physiological effect on different types of cells.

    "This shows that in order to understand Rett syndrome, we need to look beyond what's happening in neurons to other cell types," said first study author Danielle Tomasello, PhD.

    #genetics #mutation #biology #research #health #medicine #disease #RettSyndrome

    labroots.com/trending/genetics

  19. It seems that a genetic mutation may not have the same physiological effect on different types of cells.

    "This shows that in order to understand Rett syndrome, we need to look beyond what's happening in neurons to other cell types," said first study author Danielle Tomasello, PhD.

    #genetics #mutation #biology #research #health #medicine #disease #RettSyndrome

    labroots.com/trending/genetics

  20. It seems that a genetic mutation may not have the same physiological effect on different types of cells.

    "This shows that in order to understand Rett syndrome, we need to look beyond what's happening in neurons to other cell types," said first study author Danielle Tomasello, PhD.

    #genetics #mutation #biology #research #health #medicine #disease #RettSyndrome

    labroots.com/trending/genetics

  21. It seems that a genetic mutation may not have the same physiological effect on different types of cells.

    "This shows that in order to understand Rett syndrome, we need to look beyond what's happening in neurons to other cell types," said first study author Danielle Tomasello, PhD.

    #genetics #mutation #biology #research #health #medicine #disease #RettSyndrome

    labroots.com/trending/genetics

  22. Multisite clinical trial will compare three FDA-approved drugs including ketamine for Rett syndrome treatment - SCIENMAG apple.news/AlQ_hWGe6Q-eyORPwzF #ketamine #psychedelic #Rettsyndrome

  23. Multisite clinical trial will compare three FDA-approved drugs including ketamine for Rett syndrome treatment - SCIENMAG apple.news/AlQ_hWGe6Q-eyORPwzF #ketamine #psychedelic #Rettsyndrome

  24. Happy #MedicineMonday! The #FDA just approved the first treatment for #RettSyndrome, a rare, genetic, neurological disorder affecting brain development. This condition affects about 1:10,000 females, males to a far rarer extent and leads to a loss of language and motor skills developed earlier in life.

    The medication Daybue (trofinetide) is for people 2 or older, delivered orally or via gastrostomy tube.

    #DrugDevelopment #RareDisease

  25. Happy #MedicineMonday! The #FDA just approved the first treatment for #RettSyndrome, a rare, genetic, neurological disorder affecting brain development. This condition affects about 1:10,000 females, males to a far rarer extent and leads to a loss of language and motor skills developed earlier in life.

    The medication Daybue (trofinetide) is for people 2 or older, delivered orally or via gastrostomy tube.

    #DrugDevelopment #RareDisease

  26. Happy #MedicineMonday! The #FDA just approved the first treatment for #RettSyndrome, a rare, genetic, neurological disorder affecting brain development. This condition affects about 1:10,000 females, males to a far rarer extent and leads to a loss of language and motor skills developed earlier in life.

    The medication Daybue (trofinetide) is for people 2 or older, delivered orally or via gastrostomy tube.

    #DrugDevelopment #RareDisease

  27. Happy #MedicineMonday! The #FDA just approved the first treatment for #RettSyndrome, a rare, genetic, neurological disorder affecting brain development. This condition affects about 1:10,000 females, males to a far rarer extent and leads to a loss of language and motor skills developed earlier in life.

    The medication Daybue (trofinetide) is for people 2 or older, delivered orally or via gastrostomy tube.

    #DrugDevelopment #RareDisease